• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病足感染患者万古霉素的群体药代动力学:五种模型的比较

Population pharmacokinetics of vancomycin in patients with diabetic foot infection: a comparison of five models.

作者信息

Tazerouni Hedieh, Labbani-Motlagh Zohre, Amini Shahideh, Shahrami Bita, Sajjadi-Jazi Sayed Mahmoud, Afhami Shirin, Gholami Kheirollah, Sadeghi Kourosh

机构信息

Department of Clinical Pharmacy, International Campus, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

J Diabetes Metab Disord. 2023 Jul 10;22(2):1385-1390. doi: 10.1007/s40200-023-01259-5. eCollection 2023 Dec.

DOI:10.1007/s40200-023-01259-5
PMID:37975097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10638227/
Abstract

PURPOSE

This study aimed to compare individual pharmacokinetic (PK) parameters of vancomycin with predicted values from five population PK models in patients with diabetic foot infections (DFIs).

METHODS

Patients with a diagnosis of DFI and an estimated glomerular filtration rate (eGFR) ≥ 30 mL/min were included in the study. Individual PK data was carried on by collecting three vancomycin serum concentrations in a steady-state condition. Five published population-based nomograms were assumed to predict PK parameters. Optimal vancomycin exposure was considered as a trough level of 15-20 mg/L or the area under the curve over 24 h/minimum inhibitory concentration (AUC/MIC) ≥ 400.

RESULTS

A total of 48 samples from 16 patients were analyzed. There was a statistically significant difference between the volume of distribution (V) obtained from population methods and the individual estimations (P ≤ 0.001 in Ambrose and Burton, P = 0.010 and 0.006 in Bauer and Burton revised models, respectively). AUC/MIC ≥ 400 was achieved in 68.7% of patients while 50% had a trough level of less than 15 mg/L.

CONCLUSIONS

Vancomycin PK parameters, particularly individualized V, may not be predictable by population nomograms in patients with DFI and stable renal function. Moreover, the weak correlation between AUC values and trough concentrations underlines the starting practice of vancomycin AUC-based monitoring and dosing in the clinical setting.

摘要

目的

本研究旨在比较糖尿病足感染(DFI)患者中万古霉素的个体药代动力学(PK)参数与五个群体PK模型的预测值。

方法

纳入诊断为DFI且估计肾小球滤过率(eGFR)≥30 mL/min的患者。通过在稳态条件下收集三个万古霉素血清浓度来获取个体PK数据。假定使用五个已发表的基于群体的列线图来预测PK参数。最佳万古霉素暴露被认为是谷浓度为15 - 20mg/L或24小时曲线下面积/最低抑菌浓度(AUC/MIC)≥400。

结果

共分析了16例患者的48个样本。群体方法获得的分布容积(V)与个体估计值之间存在统计学显著差异(在安布罗斯和伯顿模型中P≤0.001,在鲍尔和伯顿修订模型中分别为P = 0.010和0.006)。68.7%的患者达到AUC/MIC≥400,而50%的患者谷浓度低于15mg/L。

结论

对于DFI且肾功能稳定的患者,群体列线图可能无法预测万古霉素的PK参数,尤其是个体化的V。此外,AUC值与谷浓度之间的弱相关性强调了在临床环境中基于万古霉素AUC监测和给药的起始实践。

相似文献

1
Population pharmacokinetics of vancomycin in patients with diabetic foot infection: a comparison of five models.糖尿病足感染患者万古霉素的群体药代动力学:五种模型的比较
J Diabetes Metab Disord. 2023 Jul 10;22(2):1385-1390. doi: 10.1007/s40200-023-01259-5. eCollection 2023 Dec.
2
Therapeutic Drug Monitoring of Vancomycin in Adult Patients with Methicillin-Resistant Bacteremia or Pneumonia.耐甲氧西林菌血症或肺炎成年患者万古霉素的治疗药物监测
Can J Hosp Pharm. 2021 Fall;74(4):334-343. doi: 10.4212/cjhp.v74i4.3195.
3
Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.根据仅使用谷浓度数据的药代动力学方程估算的万古霉素曲线下面积。
J Clin Pharm Ther. 2021 Oct;46(5):1426-1432. doi: 10.1111/jcpt.13474. Epub 2021 Jun 25.
4
Individualized dosing of vancomycin in geriatric patients.老年患者万古霉素的个体化给药。
Epidemiol Mikrobiol Imunol. 2020 Winter;69(4):172-180.
5
An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.万古霉素药时曲线下面积估算方法在儿童耐甲氧西林金黄色葡萄球菌急性肺部感染中的评估。
J Clin Pharmacol. 2019 Feb;59(2):198-205. doi: 10.1002/jcph.1323. Epub 2018 Oct 29.
6
Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.实施基于两点药代动力学 AUC 的万古霉素治疗药物监测方法在耐甲氧西林金黄色葡萄球菌菌血症患者中的应用。
Int J Antimicrob Agents. 2018 Dec;52(6):805-810. doi: 10.1016/j.ijantimicag.2018.08.024. Epub 2018 Aug 31.
7
Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.老年医院获得性肺炎患者中万古霉素临床疗效与新的药代动力学参数谷浓度下面积(AUTL)的相关性。
J Clin Pharm Ther. 2016 Aug;41(4):399-402. doi: 10.1111/jcpt.12399. Epub 2016 May 4.
8
Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial.基于峰谷与谷值的万古霉素治疗药物监测方法的临床和药代动力学结果:一项实用随机对照试验
Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):639-652. doi: 10.1007/s13318-019-00551-1.
9
Age-Related Differences in Vancomycin-Associated Nephrotoxicity and Efficacy in Methicillin-Resistant Infection: A Comparative Study between Elderly and Adult Patients.耐甲氧西林感染中万古霉素相关肾毒性及疗效的年龄差异:老年与成年患者的比较研究
Antibiotics (Basel). 2024 Apr 3;13(4):324. doi: 10.3390/antibiotics13040324.
10
Vancomycin area under the curve/minimum inhibitory concentration and trough level concordance-evaluation on an urban health unit.城市卫生单位中万古霉素曲线下面积/最低抑菌浓度与谷浓度的一致性评估
Ther Adv Infect Dis. 2022 Nov 28;9:20499361221140368. doi: 10.1177/20499361221140368. eCollection 2022 Jan-Dec.

引用本文的文献

1
Pharmacokinetics of Vancomycin in Healthy Korean Volunteers and Monte Carlo Simulations to Explore Optimal Dosage Regimens in Patients with Normal Renal Function.万古霉素在健康韩国志愿者中的药代动力学及蒙特卡洛模拟以探索肾功能正常患者的最佳给药方案
Antibiotics (Basel). 2024 Oct 19;13(10):993. doi: 10.3390/antibiotics13100993.
2
Effect of Compound Xuejie Powder combined with negative pressure wound therapy on diabetic foot ulcers and blood flow in the dorsal foot artery.复方血竭散联合负压伤口治疗对糖尿病足溃疡及足背动脉血流的影响。
Am J Transl Res. 2024 Sep 15;16(9):4996-5003. doi: 10.62347/XSXY3749. eCollection 2024.

本文引用的文献

1
A Moving Target-Vancomycin Therapeutic Monitoring.一个移动的目标-万古霉素治疗药物监测。
J Pediatric Infect Dis Soc. 2020 Sep 17;9(4):474-478. doi: 10.1093/jpids/piaa078.
2
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测:美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会修订的共识指南及综述
Clin Infect Dis. 2020 Sep 12;71(6):1361-1364. doi: 10.1093/cid/ciaa303.
3
The Impact of Multidrug-Resistant Organisms on Outcomes in Patients With Diabetic Foot Infections.多重耐药菌对糖尿病足感染患者预后的影响。
Open Forum Infect Dis. 2020 May 6;7(5):ofaa161. doi: 10.1093/ofid/ofaa161. eCollection 2020 May.
4
60 Plus Years Later and We Are Still Trying to Learn How to Dose Vancomycin.60多年过去了,我们仍在努力学习如何使用万古霉素进行给药。
Clin Infect Dis. 2020 Apr 10;70(8):1546-1549. doi: 10.1093/cid/ciz467.
5
Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?万古霉素群体药代动力学在脓毒症或感染性休克成人患者中的应用:目前的给药方案是否足够?
Eur J Clin Pharmacol. 2019 Sep;75(9):1219-1226. doi: 10.1007/s00228-019-02694-1. Epub 2019 Jun 1.
6
Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.从基于万古霉素谷浓度的给药方案转换为基于曲线下面积的给药方案:在成人中使用两次样本测量的实施。
Pharmacotherapy. 2019 Apr;39(4):433-442. doi: 10.1002/phar.2234. Epub 2019 Mar 18.
7
The dosing and monitoring of vancomycin: what is the best way forward?万古霉素的剂量调整与监测:何去何从?
Int J Antimicrob Agents. 2019 Apr;53(4):401-407. doi: 10.1016/j.ijantimicag.2018.12.014. Epub 2018 Dec 29.
8
Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis.脓毒症危重症患者中万古霉素的血浆和细胞间液群体药代动力学。
Int J Antimicrob Agents. 2019 Feb;53(2):137-142. doi: 10.1016/j.ijantimicag.2018.09.021. Epub 2018 Oct 5.
9
Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.实施基于两点药代动力学 AUC 的万古霉素治疗药物监测方法在耐甲氧西林金黄色葡萄球菌菌血症患者中的应用。
Int J Antimicrob Agents. 2018 Dec;52(6):805-810. doi: 10.1016/j.ijantimicag.2018.08.024. Epub 2018 Aug 31.
10
Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations.万古霉素治疗药物监测及特殊患者亚人群的群体药代动力学模型。
Pharmacol Res Perspect. 2018 Jul;6(4):e00420. doi: 10.1002/prp2.420.